{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:26:49Z","timestamp":1772166409340,"version":"3.50.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T00:00:00Z","timestamp":1682640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T00:00:00Z","timestamp":1682640000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006364","name":"Institut National Du Cancer","doi-asserted-by":"publisher","award":["PHRC-K15-182"],"award-info":[{"award-number":["PHRC-K15-182"]}],"id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Prophylactic central neck dissection in clinically low-risk cT1bT2N0 papillary thyroid carcinoma is controversial, due to a large number of conflicting retrospective studies, some showing an advantage in terms of locoregional recurrence, others showing no advantage. These previous studies all show high rates of excellent response. We aim to demonstrate the non-inferiority of thyroidectomy alone as compared to total thyroidectomy with prophylactic central neck dissection in conjunction with adjuvant RAI 30 mCi with rTSH stimulation in terms of excellent response at 1 year.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial design and methods<\/jats:title>\n                    <jats:p>Prospective randomized open multicenter phase III trial including patients with 11\u201340-mm papillary thyroid carcinoma (Bethesda VI) or suspicious cytology (Bethesda V) confirmed malignant on intra-operative frozen section analysis, with no suspicious lymph nodes on a specialized preoperative ultrasound examination. Patients will be randomized 1:1 into two groups: the reference group total thyroidectomy with bilateral prophylactic central neck dissection, and the comparator group total thyroidectomy alone. All patients will receive an ablative dose of 30mCi of radioactive iodine (RAI) within 4 months of surgery. The primary outcome is to compare the rate of excellent response at 1 year after surgery between the groups, as defined by an unstimulated serum thyroglobulin (Tg) level \u2264 0.2 ng\/mL with no anti-Tg antibodies, an normal neck ultrasound and no ectopic uptake on the post-RAI scintiscan. Non-inferiority will be demonstrated if the rate of patients with excellent response at 1 year after randomization does not differ by more than 5%. Setting the significance level at 0.025 (one-sided) and a power of 80% requires a sample size of 598 patients (299 per group). Secondary outcomes are to compare Tg levels at 8 +\/\u2212 2 postoperative weeks, before RAI ablation, the rate of excellent response at 3 and 5 years, the rate of other responses at 1, 3, and 5 years (biochemical incomplete, indeterminate, and structurally incomplete responses), complications, quality of life, and cost-utility.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion (potential implications)<\/jats:title>\n                    <jats:p>If non-inferiority is demonstrated with this high-level evidence, prophylactic neck dissection will have been shown to not be necessary in clinically low-risk papillary thyroid carcinoma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>NCT 03570021. June 26,2018<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13063-023-07294-0","type":"journal-article","created":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T01:02:29Z","timestamp":1682643749000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["ESTIMation of the ABiLity of prophylactic central compartment neck dissection to modify outcomes in low-risk differentiated thyroid cancer: a prospective randomized trial"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1161-5628","authenticated-orcid":false,"given":"Dana","family":"Hartl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yann","family":"Godbert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier","family":"Carrat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phane","family":"Bardet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Audrey","family":"Lasne-Cardon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Vera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Ilies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Slimane","family":"Zerdoud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00e9r\u00f4me","family":"Sarini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamad","family":"Zalzali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"La Manna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Schneegans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antony","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philppe","family":"Kauffmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrice","family":"Rodien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurent","family":"Brunaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Solange","family":"Grunenwald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elie","family":"Housseau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salim","family":"Laghouati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie","family":"Bouvet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elodie","family":"Lecerf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julien","family":"Hadoux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Livia","family":"Lamartina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Schlumberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"Borget","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,4,28]]},"reference":[{"issue":"3","key":"7294_CR1","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1002\/bjs.8985","volume":"100","author":"M Barczynski","year":"2013","unstructured":"Barczynski M, Konturek A, Stopa M, Nowak W. Prophylactic central neck dissection for papillary thyroid cancer. Br J Surg. 2013;100(3):410\u20138.","journal-title":"Br J Surg"},{"issue":"6","key":"7294_CR2","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.surg.2011.09.003","volume":"150","author":"A Popadich","year":"2011","unstructured":"Popadich A, Levin O, Lee JC, Smooke-Praw S, Ro K, Fazel M, et al. A multicenter cohort study of total thyroidectomy and routine central lymph node dissection for cN0 papillary thyroid cancer. Surgery. 2011;150(6):1048\u201357.","journal-title":"Surgery"},{"issue":"8","key":"7294_CR3","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1007\/s00268-013-2089-3","volume":"37","author":"DM Hartl","year":"2013","unstructured":"Hartl DM, Mamelle E, Borget I, Leboulleux S, Mirghani H, Schlumberger M. Influence of prophylactic neck dissection on rate of retreatment for papillary thyroid carcinoma. World J Surg. 2013;37(8):1951\u20138.","journal-title":"World J Surg"},{"issue":"12","key":"7294_CR4","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1089\/thy.2010.0178","volume":"20","author":"RM Tuttle","year":"2010","unstructured":"Tuttle RM, Tala H, Shah J, Leboeuf R, Ghossein R, Gonen M, et al. Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: using response to therapy variables to modify the initial risk estimates predicted by the new American Thyroid Association staging system. Thyroid. 2010;20(12):1341\u20139.","journal-title":"Thyroid"},{"issue":"4","key":"7294_CR5","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1210\/jc.2008-1931","volume":"94","author":"S Bonnet","year":"2009","unstructured":"Bonnet S, Hartl D, Leboulleux S, Baudin E, Lumbroso JD, Al Ghuzlan A, et al. Prophylactic lymph node dissection for papillary thyroid cancer less than 2 cm: implications for radioiodine treatment. J Clin Endocrinol Metab. 2009;94(4):1162\u20137.","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"7294_CR6","doi-asserted-by":"publisher","first-page":"3477","DOI":"10.1245\/s10434-013-3125-0","volume":"20","author":"TS Wang","year":"2013","unstructured":"Wang TS, Cheung K, Farrokhyar F, Roman SA, Sosa JA. A meta-analysis of the effect of prophylactic central compartment neck dissection on locoregional recurrence rates in patients with papillary thyroid cancer. Ann Surg Oncol. 2013;20(11):3477\u201383.","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"7294_CR7","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1089\/thy.2012.0608","volume":"23","author":"BH Lang","year":"2013","unstructured":"Lang BH, Ng SH, Lau LL, Cowling BJ, Wong KP, Wan KY. A systematic review and meta-analysis of prophylactic central neck dissection on short-term locoregional recurrence in papillary thyroid carcinoma after total thyroidectomy. Thyroid. 2013;23(9):1087\u201398.","journal-title":"Thyroid"},{"issue":"8","key":"7294_CR8","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1007\/s00268-002-6612-1","volume":"26","author":"ID Hay","year":"2002","unstructured":"Hay ID, Thompson GB, Grant CS, Bergstralh EJ, Dvorak CE, Gorman CA, et al. Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940\u20131999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients. World J Surg. 2002;26(8):879\u201385.","journal-title":"World J Surg"},{"issue":"9","key":"7294_CR9","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1089\/thy.2012.0011","volume":"22","author":"D Giordano","year":"2012","unstructured":"Giordano D, Valcavi R, Thompson GB, Pedroni C, Renna L, Gradoni P, et al. Complications of central neck dissection in patients with papillary thyroid carcinoma: results of a study on 1087 patients and review of the literature. Thyroid. 2012;22(9):911\u20137.","journal-title":"Thyroid"},{"issue":"5","key":"7294_CR10","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.surg.2009.01.013","volume":"145","author":"R Alvarado","year":"2009","unstructured":"Alvarado R, Sywak MS, Delbridge L, Sidhu SB. Central lymph node dissection as a secondary procedure for papillary thyroid cancer: is there added morbidity? Surgery. 2009;145(5):514\u20138.","journal-title":"Surgery"},{"issue":"3","key":"7294_CR11","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1001\/archsurg.2010.9","volume":"145","author":"WT Shen","year":"2010","unstructured":"Shen WT, Ogawa L, Ruan D, Suh I, Kebebew E, Duh QY, et al. Central neck lymph node dissection for papillary thyroid cancer: comparison of complication and recurrence rates in 295 initial dissections and reoperations. Arch Surg. 2010;145(3):272\u20135.","journal-title":"Arch Surg"},{"issue":"6","key":"7294_CR12","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1016\/j.surg.2013.06.016","volume":"154","author":"K Zanocco","year":"2013","unstructured":"Zanocco K, Elaraj D, Sturgeon C. Routine prophylactic central neck dissection for low-risk papillary thyroid cancer: a cost-effectiveness analysis. Surgery. 2013;154(6):1148\u201355 discussion 54-5.","journal-title":"Surgery."},{"issue":"1","key":"7294_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","volume":"26","author":"BR Haugen","year":"2016","unstructured":"Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016;26(1):1\u2013133.","journal-title":"Thyroid"},{"issue":"7","key":"7294_CR14","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1507\/endocrj.EJ20-0025","volume":"67","author":"Y Ito","year":"2020","unstructured":"Ito Y, Onoda N, Okamoto T. The revised clinical practice guidelines on the management of thyroid tumors by the Japan Associations of Endocrine Surgeons: Core questions and recommendations for treatments of thyroid cancer. Endocrine J. 2020;67(7):669\u2013717.","journal-title":"Endocrine J"},{"key":"7294_CR15","unstructured":"Geurrier B, Berthet JP, Cartier C, Dehesdin D, Edet-Sanson A, Le Clech G, et al. Argumentaire de la recommandation: Prise en charge des cancers diff\u00e9renci\u00e9s de souche folliculaire du corps thyro\u00efde de l\u2019adulte. In: Soci\u00e9t\u00e9 Fran\u00e7aise d'Oto-rhino-laryngologie et de Chirurgie de la Face et du Cou, Editor. Pathologies chirurgicales des la glande thyro\u00efde. Saint-Cloud: L\u2019Europ\u00e9enn d\u2019\u00e9dition. 2012. p. 491-581."},{"issue":"3","key":"7294_CR16","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s00423-013-1057-6","volume":"398","author":"H Dralle","year":"2013","unstructured":"Dralle H, Musholt TJ, Schabram J, Steinmuller T, Frilling A, Simon D, et al. German Association of Endocrine Surgeons practice guideline for the surgical management of malignant thyroid tumors. Langenbeck\u2019s Arch Surg. 2013;398(3):347\u201375.","journal-title":"Langenbeck\u2019s Arch Surg"},{"issue":"S2","key":"7294_CR17","doi-asserted-by":"publisher","first-page":"S150","DOI":"10.1017\/S0022215116000578","volume":"130","author":"AL Mitchell","year":"2016","unstructured":"Mitchell AL, Gandhi A, Scott-Coombes D, Perros P. Management of thyroid cancer: United Kingdom National Multidisciplinary Guidelines. J Laryngol Otol. 2016;130(S2):S150\u201360.","journal-title":"J Laryngol Otol"},{"issue":"12","key":"7294_CR18","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1093\/annonc\/mdz400","volume":"30","author":"S Filetti","year":"2019","unstructured":"Filetti S, Durante C, Hartl D, Leboulleux S, Locati LD, Newbold K, et al. Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-updagger. Ann Oncol. 2019;30(12):1856\u201383.","journal-title":"Ann Oncol"},{"key":"7294_CR19","unstructured":"Association Francophone de Chirurgie Endocrinienne. Conf\u00e9rence de consensus: Prise en charge des cancers thyro\u00efdiens diff\u00e9renci\u00e9s de souche v\u00e9siculaire. France; 2019. Available from: https:\/\/afce-chirurgie-endocrinienne.com\/wp-content\/uploads\/2019\/11\/afce_concensus_cancerthyroide0907.pdf."},{"issue":"1","key":"7294_CR20","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3322\/caac.21166","volume":"63","author":"R Siegel","year":"2013","unstructured":"Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63(1):11\u201330.","journal-title":"CA Cancer J Clin"},{"key":"7294_CR21","unstructured":"Defossez G LG-PS, Uhry Z, Grosclaude P, Colonna M, Dantony E, et al. Estimations nationales de l'incidence et de la mortalit\u00e9 par cancer en France m\u00e9tropolitaine entre 1990 et 2018. Synth\u00e8se. Saint-Maurice: Sant\u00e9 Publique France; 2019. Available from: https:\/\/www.santepubliquefrance.fr\/maladies-et-traumatismes\/cancers\/cancer-du-sein\/documents\/rapport-synthese\/estimations-nationales-de-l-incidence-et-de-la-mortalite-par-cancer-en-france-metropolitaine-entre-1990-et-2018-volume-1-tumeurs-solides-etud."},{"issue":"4","key":"7294_CR22","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1530\/EJE-07-0603","volume":"158","author":"S Bardet","year":"2008","unstructured":"Bardet S, Malville E, Rame JP, Babin E, Samama G, De Raucourt D, et al. Macroscopic lymph-node involvement and neck dissection predict lymph-node recurrence in papillary thyroid carcinoma. Eur J Endocrinol. 2008;158(4):551\u201360.","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"7294_CR23","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1089\/thy.2012.0043","volume":"22","author":"GW Randolph","year":"2012","unstructured":"Randolph GW, Duh QY, Heller KS, LiVolsi VA, Mandel SJ, Steward DL, et al. The prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension. Thyroid. 2012;22(11):1144\u201352.","journal-title":"Thyroid"},{"issue":"2","key":"7294_CR24","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00423-013-1152-8","volume":"399","author":"JJ Sancho","year":"2014","unstructured":"Sancho JJ, Lennard TW, Paunovic I, Triponez F, Sitges-Serra A. Prophylactic central neck disection in papillary thyroid cancer: a consensus report of the European Society of Endocrine Surgeons (ESES). Langenbeck\u2019s Arch Surg. 2014;399(2):155\u201363.","journal-title":"Langenbeck\u2019s Arch Surg"},{"issue":"6","key":"7294_CR25","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1245\/s10434-012-2849-6","volume":"20","author":"BH Lang","year":"2013","unstructured":"Lang BH, Ng SH, Lau LL, Cowling BJ, Wong KP. A systematic review and meta-analysis comparing the efficacy and surgical outcomes of total thyroidectomy between harmonic scalpel versus ligasure. Ann Surg Oncol. 2013;20(6):1918\u201326.","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"7294_CR26","doi-asserted-by":"publisher","first-page":"2846","DOI":"10.1007\/s00268-018-4547-4","volume":"42","author":"L Chen","year":"2018","unstructured":"Chen L, Wu YH, Lee CH, Chen HA, Loh EW, Tam KW. Prophylactic central neck dissection for papillary thyroid carcinoma with clinically uninvolved central neck lymph nodes: a systematic review and meta-analysis. World J Surg. 2018;42(9):2846\u201357.","journal-title":"World J Surg"},{"issue":"7","key":"7294_CR27","first-page":"579","volume":"23","author":"EL Mazzaferri","year":"2009","unstructured":"Mazzaferri EL. What is the optimal initial treatment of low-risk papillary thyroid cancer (and why is it controversial)? Oncology (Williston Park,NY.). 2009;23(7):579\u201388.","journal-title":"Oncology (Williston Park, N.Y.)"},{"issue":"3","key":"7294_CR28","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1002\/bjs.10036","volume":"103","author":"IJ Nixon","year":"2016","unstructured":"Nixon IJ, Wang LY, Ganly I, Patel SG, Morris LG, Migliacci JC, et al. Outcomes for patients with papillary thyroid cancer who do not undergo prophylactic central neck dissection. Br J Surg. 2016;103(3):218\u201325.","journal-title":"Br J Surg"},{"issue":"7","key":"7294_CR29","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1007\/s00405-014-3104-5","volume":"272","author":"E Mamelle","year":"2015","unstructured":"Mamelle E, Borget I, Leboulleux S, Mirghani H, Suarez C, Pellitteri PK, et al. Impact of prophylactic central neck dissection on oncologic outcomes of papillary thyroid carcinoma: a review. Eur Arch Oto-Rhino-L. 2015;272(7):1577\u201386.","journal-title":"Eur Arch Oto-Rhino-L"},{"issue":"1","key":"7294_CR30","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1097\/SLA.0000000000005388","volume":"276","author":"A Sanabria","year":"2022","unstructured":"Sanabria A, Betancourt-Aguero C, Sanchez-Delgado JG, Garcia-Lozano C. Prophylactic central neck lymph node dissection in low-risk thyroid carcinoma patients does not decrease the incidence of locoregional recurrence: a meta-analysis of randomized trials. Ann Surg. 2022;276(1):66\u201373.","journal-title":"Ann Surg"},{"issue":"1","key":"7294_CR31","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.surg.2021.03.071","volume":"171","author":"JH Ahn","year":"2022","unstructured":"Ahn JH, Kwak JH, Yoon SG, Yi JW, Yu HW, Kwon H, et al. A prospective randomized controlled trial to assess the efficacy and safety of prophylactic central compartment lymph node dissection in papillary thyroid carcinoma. Surgery. 2022;171(1):182\u20139.","journal-title":"Surgery"},{"issue":"3","key":"7294_CR32","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1097\/SLA.0000000000004345","volume":"272","author":"RS Sippel","year":"2020","unstructured":"Sippel RS, Robbins SE, Poehls JL, Pitt SC, Chen H, Leverson G, et al. A Randomized controlled clinical trial: no clear benefit to prophylactic central neck dissection in patients with clinically node negative papillary thyroid cancer. Ann Surg. 2020;272(3):496\u2013503.","journal-title":"Ann Surg"},{"key":"7294_CR33","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/571480","volume":"2015","author":"DY Lee","year":"2015","unstructured":"Lee DY, Oh KH, Cho JG, Kwon SY, Woo JS, Baek SK, et al. The benefits and risks of prophylactic central neck dissection for papillary thyroid carcinoma: prospective cohort study. Int J Endocrinol. 2015;2015: 571480.","journal-title":"Int J Endocrinol"},{"issue":"4","key":"7294_CR34","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1210\/jc.2014-3825","volume":"100","author":"D Viola","year":"2015","unstructured":"Viola D, Materazzi G, Valerio L, Molinaro E, Agate L, Faviana P, et al. Prophylactic central compartment lymph node dissection in papillary thyroid carcinoma: clinical implications derived from the first prospective randomized controlled single institution study. J Clin Endocrinol Metab. 2015;100(4):1316\u201324.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"7294_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.14639\/0392-100X-1195","volume":"37","author":"J Liang","year":"2017","unstructured":"Liang J, Li Z, Fang F, Yu T, Li S. Is prophylactic central neck dissection necessary for cN0 differentiated thyroid cancer patients at initial treatment? A meta-analysis of the literature. Acta Otorhinolaryngol Ital. 2017;37(1):1\u20138.","journal-title":"Acta Otorhinolaryngol Ital"},{"issue":"8","key":"7294_CR36","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1245\/s10434-016-5691-4","volume":"24","author":"W Zhao","year":"2017","unstructured":"Zhao W, You L, Hou X, Chen S, Ren X, Chen G, et al. The effect of prophylactic central neck dissection on locoregional recurrence in papillary thyroid cancer after total thyroidectomy: a systematic review and meta-analysis\u202f: pCND for the locoregional recurrence of papillary thyroid cancer. Ann Surg Oncol. 2017;24(8):2189\u201398.","journal-title":"Ann Surg Oncol"},{"key":"7294_CR37","doi-asserted-by":"publisher","first-page":"3287","DOI":"10.1245\/s10434-010-1137-6","volume":"12","author":"T Zetoune","year":"2010","unstructured":"Zetoune T, Keutgen X, Buitrago D, Aldailami H, Shao H, Mazumdar M, et al. Prophylactic central neck dissection and local recurrence in papillary thyroid cancer: a meta-analysis. Ann Surg Oncol. 2010;12:3287\u201393. https:\/\/doi.org\/10.1245\/s10434-010-1137-6.","journal-title":"Ann Surg Oncol."},{"issue":"11","key":"7294_CR38","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1089\/thy.2009.0159","volume":"19","author":"American Thyroid Association Surgery Working G, American Association of Endocrine S, American Academy of O-H, Neck S, American H, Neck S","year":"2009","unstructured":"American Thyroid Association Surgery Working G, American Association of Endocrine S, American Academy of O-H, Neck S, American H, Neck S, et al. Consensus statement on the terminology and classification of central neck dissection for thyroid cancer. Thyroid. 2009;19(11):1153\u20138.","journal-title":"Thyroid"},{"issue":"3","key":"7294_CR39","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1089\/thy.2011.0317","volume":"22","author":"T Carling","year":"2012","unstructured":"Carling T, Carty SE, Ciarleglio MM, Cooper DS, Doherty GM, Kim LT, et al. American Thyroid Association design and feasibility of a prospective randomized controlled trial of prophylactic central lymph node dissection for papillary thyroid carcinoma. Thyroid. 2012;22(3):237\u201344.","journal-title":"Thyroid"},{"issue":"18","key":"7294_CR40","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1056\/NEJMoa1108586","volume":"366","author":"M Schlumberger","year":"2012","unstructured":"Schlumberger M, Catargi B, Borget I, Deandreis D, Zerdoud S, Bridji B, et al. Strategies of radioiodine ablation in patients with low-risk thyroid cancer. New Engl J Med. 2012;366(18):1663\u201373.","journal-title":"New Engl J Med"},{"issue":"10","key":"7294_CR41","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1056\/NEJMoa2111953","volume":"386","author":"S Leboulleux","year":"2022","unstructured":"Leboulleux S, Bournaud C, Chougnet CN, Zerdoud S, Al Ghuzlan A, Catargi B, et al. Thyroidectomy without radioiodine in patients with low-risk thyroid cancer. New Engl J Med. 2022;386(10):923\u201332.","journal-title":"New Engl J Med"},{"issue":"5","key":"7294_CR42","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.clon.2008.03.010","volume":"20","author":"U Mallick","year":"2008","unstructured":"Mallick U, Harmer C, Hackshaw A. The HiLo trial: a multicentre randomised trial of high- versus low-dose radioiodine, with or without recombinant human thyroid stimulating hormone, for remnant ablation after surgery for differentiated thyroid cancer. Clin Oncol. 2008;20(5):325\u20136.","journal-title":"Clin Oncol"},{"issue":"5","key":"7294_CR43","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1210\/jc.2010-2708","volume":"96","author":"M Brassard","year":"2011","unstructured":"Brassard M, Borget I, Edet-Sanson A, Giraudet AL, Mundler O, Toubeau M, et al. Long-term follow-up of patients with papillary and follicular thyroid cancer: a prospective study on 715 patients. J Clin Endocrinol Metab. 2011;96(5):1352\u20139.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"7294_CR44","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1210\/jc.2012-3401","volume":"98","author":"C Durante","year":"2013","unstructured":"Durante C, Montesano T, Torlontano M, Attard M, Monzani F, Tumino S, et al. Papillary thyroid cancer: time course of recurrences during postsurgery surveillance. J Clin Endocrinol Metab. 2013;98(2):636\u201342.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"7294_CR45","first-page":"307","volume":"125","author":"V Woisard","year":"2004","unstructured":"Woisard V, Bodin S, Puech M. The Voice Handicap Index: impact of the translation in French on the validation. Revue de laryngologie - otologie - rhinologie. 2004;125(5):307\u201312.","journal-title":"Revue de laryngologie - otologie - rhinologie"},{"issue":"3","key":"7294_CR46","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.gcb.2008.12.012","volume":"33","author":"E Khaldoun","year":"2009","unstructured":"Khaldoun E, Woisard V, Verin E. Validation in French of the SWAL-QOL scale in patients with oropharyngeal dysphagia. Gastroenterol Clin Biol. 2009;33(3):167\u201371.","journal-title":"Gastroenterol Clin Biol"},{"issue":"11","key":"7294_CR47","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/S0895-4356(98)00093-6","volume":"51","author":"A Leplege","year":"1998","unstructured":"Leplege A, Ecosse E, Verdier A, Perneger TV. The French SF-36 Health Survey: translation, cultural adaptation and preliminary psychometric evaluation. J Clin Epidemiol. 1998;51(11):1013\u201323.","journal-title":"J Clin Epidemiol"},{"key":"7294_CR48","unstructured":"Questionnaire sur la sant\u00e9 EQ- 5D. Version fran\u00e7aise pour le Canada (French version for Canada). Available from: https:\/\/sante.gouv.fr\/IMG\/pdf\/proms_eq5d5l_generique.pdf."},{"issue":"4","key":"7294_CR49","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1037\/h0078881","volume":"25","author":"JBS Gauthier","year":"1993","unstructured":"Gauthier JBS. Adaptation canadienne-fran\u00e7aise de la forme r\u00e9vis\u00e9e du State-Trait Anxiety Inventory de Spielberger [A French-Canadian adaptation of the revised version of Spielberger\u2019s State-Trait Anxiety Inventory. Can J Behav Sci. 1993;25(4):559\u201378.","journal-title":"Can J Behav Sci"},{"key":"7294_CR50","volume-title":"TNM Classification of Malignant Tumors","author":"J Brierley","year":"2017","unstructured":"Brierley J, Gospodarowicz M, Wittekind C. TNM Classification of Malignant Tumors. 8th ed. Oxford: Wiley Blackwell; 2017.","edition":"8"},{"issue":"11","key":"7294_CR51","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1089\/thy.2017.0500","volume":"27","author":"ES Cibas","year":"2017","unstructured":"Cibas ES, Ali SZ. The 2017 Bethesda System for Reporting Thyroid Cytopathology. Thyroid. 2017;27(11):1341\u20136.","journal-title":"Thyroid"},{"issue":"3","key":"7294_CR52","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1159\/000354537","volume":"2","author":"L Leenhardt","year":"2013","unstructured":"Leenhardt L, Erdogan MF, Hegedus L, Mandel SJ, Paschke R, Rago T, et al. 2013 European thyroid association guidelines for cervical ultrasound scan and ultrasound-guided techniques in the postoperative management of patients with thyroid cancer. Eur Thyr J. 2013;2(3):147\u201359.","journal-title":"Eur Thyr J"},{"issue":"4","key":"7294_CR53","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1097\/SLA.0b013e31824b7b68","volume":"255","author":"DM Hartl","year":"2012","unstructured":"Hartl DM, Leboulleux S, Al Ghuzlan A, Baudin E, Chami L, Schlumberger M, et al. Optimization of staging of the neck with prophylactic central and lateral neck dissection for papillary thyroid carcinoma. Ann Surg. 2012;255(4):777\u201383.","journal-title":"Ann Surg"},{"key":"7294_CR54","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e7586","volume":"346","author":"AW Chan","year":"2013","unstructured":"Chan AW, Tetzlaff JM, Gotzsche PC, Altman DG, Mann H, Berlin JA, et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ. 2013;346: e7586.","journal-title":"BMJ"},{"issue":"26","key":"7294_CR55","doi-asserted-by":"publisher","first-page":"2885","DOI":"10.1200\/JCO.2015.61.6722","volume":"33","author":"I Borget","year":"2015","unstructured":"Borget I, Bonastre J, Catargi B, Deandreis D, Zerdoud S, Rusu D, et al. Quality of life and cost-effectiveness assessment of radioiodine ablation strategies in patients with thyroid cancer: results from the randomized phase III ESTIMABL trial. J Clin Oncol. 2015;33(26):2885\u201392.","journal-title":"J Clin Oncol"}],"updated-by":[{"DOI":"10.1186\/s13063-023-07467-x","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T00:00:00Z","timestamp":1689033600000}}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-023-07294-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-023-07294-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-023-07294-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T03:04:52Z","timestamp":1689131092000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-023-07294-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,28]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["7294"],"URL":"https:\/\/doi.org\/10.1186\/s13063-023-07294-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2643673\/v1","asserted-by":"object"}]},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,28]]},"assertion":[{"value":"1 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2023","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s13063-023-07467-x","URL":"https:\/\/doi.org\/10.1186\/s13063-023-07467-x","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The clinical trial is conducted in conformity with:- Ethical principles stated in the Declaration of Helsinki 1964, as revised in Fortaleza, 2013- The European Directive (2001\/20\/EC and 2005\/28\/EC)- Directive 95\/46\/CE on the processing of personal data- Appendix 13 of the E. U. Guide to Good Manufacturing Practices (revised and adopted in February 2010 by the European Commission),- The Good Clinical Practices guidelines (International Conference on Harmonization ICH E6) and Statistical Principles for Clinical Trials (ICH E9),- The Clinical Safety Data Management guidance (ICH E2A), and- Any local Regulations including\u25cb French Public Healthcare Law (n\u00b0 2004-806) of August 9, 2004, a partial adaptation of the European Directive (2001\/20\/EC) on the conduct of clinical trials,\u25cb French Public Healthcare Law (n\u00b0 2016-41) of January 26, 2004, about modernization of the health system,\u25cb Ordinance n\u00b02016-800 of June 16, 2016, on medical research involving human subjects,\u25cb French Informatics and Liberties Law (n\u00b0 78-17) of January 6, 1978 modified by Law n\u00b0 2004-801 of August 6, 2004, relative to the protection of physical persons with respect to the treatment of personal information,\u25cb French Law n\u00b0 2002-303 of March 4, 2002, relative to patients\u2019 rights and to the quality of the healthcare system.The first act of recruitment (i.e., start of the clinical trial) is defined as being of the first site initiation visit.The first visit of the first subject is defined as being the date of signature of the consent form by the first patient, i.e., first inclusion in the trial.The end of the trial is defined as being the last-protocol-specified visit of the last patient, i.e., 5 years after randomization for the last patient.This protocol was submitted to the French National Research Ethics Committee (CPP IDF 2) which gave its approval on 13\/02\/2018 (annex\n                      \n                      ).Gustave Roussy has taken out a legal liability insurance policy (N\u00b0124.895) (annex\n                      \n                      ).A clinical study report on the trial will be written at the latest, 1 year after the end of the trial. Results will be sent to the competent authority and to the Ethic Committee.Results of the long-term follow-up might be available in medical publication format after availability of the Clinical Study Report.Gustave Roussy will maintain records of essential trial documentation in the Sponsor file for a minimum duration of 15 years after the end of the trial.It is the responsibility of the investigator to obtain a signed informed consent from each patient (or his\/her legal representative when required) prior to participating in this study. Consent should be obtained before any study-related procedure and after adequate explanation of the aims, methods, anticipated benefits, potential hazards, and requirements imposed by the study.The patient \/ legal representative will be provided with an information and consent form in comprehensive, clear, relevant, and simple language. Adequate time shall be given for the patient (or his\/her legally designated representative) to consider his\/her decision to participate in the clinical trial. Patient (or his\/her legal representative) should be informed about his\/her right to refuse to participate and the right to withdraw from the trial at any time without any resulting detriment and without having to provide any justification.Having read the information notice, the patient (or legal representative) must date and sign the consent form if he\/she accepts to participate. This consent form must also be signed by the investigator. The original consent form must be kept in the study file by the investigator and the study participant (or his\/her legal representative) should receive a copy.During a patient\u2019s participation in the trial, any update to the consent form and any update to the written information will be provided to the patient.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"It is not planned to publish other related patient documents (photographs or videos), so that this type of consent is not applicable to the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"298"}}